Hypoxyprobe - 200 mg of Pimonidazole Hydrochloride solidhttp://www.hypoxyprobe.com/hp-200mg.html

The University of Virginia awarded contract A207_PO-0466905 to Hypoxyprobe Inc on August 8, 2026, with a total contract value of $440. The prime contractor is obligated to deliver one unit of Pimonidazole Hydrochloride solid in a 200 milligram formulation to the designated recipient, Katie Knight. This pharmaceutical product is sourced from Hypoxyprobe's established product line and represents a specialized chemical compound utilized in research applications.

The award represents a straightforward procurement of a single line item product with no additional services specified in the contract documentation. As a Virginia-based state institution, the University of Virginia executed this purchase through its standard procurement process. The minimal contract value and singular deliverable indicate this transaction constitutes a routine materials acquisition rather than a comprehensive supply or services agreement with extended performance obligations.